Mizuho Securities USA’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Mizuho Securities USA’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-668,429	Closed	-$6.68M	–	262
2022 Q2	$6.68M	Sell	668,429 -73,571	-10%	-$744K	1.03%	20
2022 Q1	$7.42M	Sell	742,000 -8,000	-1%	-$80.3K	1.06%	23
2021 Q4	$7.46M	Buy	+750,000	New	+$7.49M	0.67%	27

Other funds holding OCEA

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

ASM

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Mizuho Securities USA's OCEA Position: Q3 2022 in Review

Mizuho Securities USA sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q3 2022, closing a stake of 668,429 shares — an estimated $6.68M sold.

Mizuho Securities USA first reported a position in OCEA in Q4 2021 and held it in 3 quarters. The position peaked at $7.46M in Q4 2021. 40 funds tracked by Wall St. Rank hold OCEA as of Q3 2022.

Mizuho Securities USA reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Mizuho Securities USA sold 668,429 Ocean Biomedical, Inc. Common Stock shares in Q3 2022, an estimated $6.68M.
Mizuho Securities USA first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Mizuho Securities USA's Ocean Biomedical, Inc. Common Stock position peaked at $7.46M in Q4 2021.
40 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q3 2022.

Based on Mizuho Securities USA's 13F filing for Q3 2022, filed 24 Oct 2022.